Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
114 EUR | +0.13% | -.--% | -.--% |
Apr. 11 | U.S. Futures Down, European Stocks Mixed | DJ |
Apr. 08 | DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital. | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 57.24 times its estimated earnings per share for the ongoing year.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Consumer Goods Conglomerates
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 29.19B | A | ||
+12.70% | 876B | - | D+ | |
0.00% | 239B | - | C | |
+26.35% | 177B | B | ||
-7.96% | 126B | B- | ||
+32.50% | 78.86B | B+ | ||
-5.26% | 74.14B | B | ||
-16.38% | 50.58B | C+ | ||
-22.98% | 38.71B | - | - | |
+19.71% | 32.18B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DSFIR Stock
- DSM Stock
- Ratings Koninklijke DSM